MOLECULAR DIAGNOSTICS CONFERENCE

5 February 2018

5.75 CME Points

Za’abeel Hall 6, Conference Room 2

Overview

Molecular diagnostics is being applied to the clinical setting for greater speed and accuracy of healthcare delivery, while paving the way for a new era in medicine.  New molecular-based tools are rapidly entering the laboratories and creating a new paradigm in healthcare.This

Molecular Diagnostics conference at MEDLAB will bring together a balance of industry and academe, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various researches and studies on molecular and non-molecular rapid diagnostic techniques and Next Generation Sequencing.

Key Topics:

  • Current and future biomarkers of inflammation
  • Molecular tools in pathogen surveillance and outbreaks
  • Next Generation Sequencing (NGS) for molecular diagnostics 
  • NGS for Hepatitis C virus
  • NGS for outbreak investigation

Benefits of attending

  • Evaluate current and future biomarkers
  • Review technology and its applications for molecular diagnostics
  • Discuss test validation and verification in the molecular laboratory
  • Examine application of gene therapy or biologic response modifiers

 

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics | Beckman Coulter | Siemens Healthineers

Supported by:

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics
Beckman Coulter
Siemens Healthineers

09:50

Opening remarks by the chair

Dr Mohammed Naveed, Consultant Geneticist, Department of Paediatrics, Fujairah Hospital, Ministry of Health and Prevention, Fujairah, UAE

Session 1

Moderator: Dr Mohammed Naveed, Consultant Geneticist, Department of Paediatrics, Fujairah Hospital, Ministry of Health and Prevention, Fujairah, UAE

10:00

Genomics-based interventions for public health improvement in Arab countries - major challenges

Dr Kalthoom Mohammed, Director, Hospitals Department, Hospital Sector, Ministry of Health & Prevention, Dubai, UAE

10:30

The Saudi Human Genome Programme - progress and future directions

Dr Brian Meyer, Chairman, Department of Genetics, Research Centre, King Faisal Specialist Hospital and Research Centre, Jeddah, KSA

11:00 Coffee Break


Session 2

Moderator: Dr Imran Mirza, Chief, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

11:30

Clinical exome sequencing in rare Mendelian disorders

Dr Pascal Joset, Professor, Institute of Medical Genetics, University of Zurich, Zurich, Switzerland

12:00

Setting up a scalable bioinformatics infrastructure for high throughput genomics

Nizar Drou, Core Bioinformatics lead Developer, CGSB NYU, Abu Dhabi, UAE

12:30

Good or bad sequencing data? Setting a benchmark for the quality of NGS in the diagnostic lab

Dr Simon Patton, Director, European Molecular Genetics Quality Network (EMQN) c/o Manchester Centre for Genomic Medicine, Manchester, UK

13:00 Lunch Break


Session 3

Moderator: Ahmed Al Marzouqi, Associate Professor, Department of Biochemistry, College of Medicine and Health Sciences, UAE University, Al Ain, UAE

14:00

Prenatal genomic evaluations: a laboratory perspective

Dr Linda B. Baughn, Medical Geneticist, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

14:30

Mutational landscape of autism spectrum disorder

Dr Mohammed Uddin, Assistant Professor, Human Genetics, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE

15:00 Coffee Break


Session 4

Moderator: Dr Fatma Bastaki, Consultant Pediatrician and Clinical Geneticist and Metabolist, Latifa Hospital, Dubai Health Authority, Dubai, UAE

16:00

The revolution of clinical genomics in medical genetics

Dr Jorge Pinto Basto, Specialist in Medical Genetics; Clinical Director, CGC Genetics, Porto, Portugal

16:30

Adapting ACMG incidental findings gene panel in predictive/diagnostic genetic testing in Kuwait

Dr Rabeah Abbas Al-Temaimi, Head of Human Genetic Unit, Department of Pathology Faculty of Medicine, Kuwait University, Kuwait

17:00

Non-invasive prenatal diagnostics

Dr Kuldeep Singh, Consultant Geneticist, Head of Department of Pediatrics & Genetics; Dean, All India Institutes of Medical Sciences, New Delhi, India

17:30

Quality considerations for clinical use of stem cells

Dr Manoj Kumar, Stem Cell Laboratory Manager, Buhoot Equine Research Center, Dubai, UAE

18:00 End of conference

Supported by:

ACTIVITY DIRECTORS:

Dr Mansour Al Zarouni, Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Lab Med Institute, Cleveland Clinic, Cleveland, Ohio, USA


PLANNING COMMITTEE:

Dr Mohammed Naveed, Consultant Geneticist, Department of Paediatrics, Fujairah Hospital, Ministry of Health and Prevention, Fujairah, UAE

Dr Imran Mirza, Chief, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE


SPEAKER FACULTY:

Ahmed Al Marzouqi, Associate Professor, Department of Biochemistry, College of Medicine and Health Sciences, UAE University, Al Ain, UAE

Dr Brian Meyer, Chairman, Department of Genetics, Research Centre, King Faisal Specialist Hospital and Research Centre, Jeddah, KSA

Dr Fatma Bastaki, Consultant Pediatrician and Clinical Geneticist and Metabolist, Latifa Hospital, Dubai Health Authority, Dubai, UAE

Dr Jorge Pinto Basto, Specialist in Medical Genetics; Clinical Director, CGC Genetics, Portugal

Dr Kalthoom Mohammed, Director, Hospitals Department, Hospital Sector, Ministry of Health & Prevention, Dubai, UAE

Dr Kuldeep Singh, Consultant Geneticist, Head of Department of Pediatrics & Genetics; Dean, All India Institutes of Medical Sciences, New Delhi, India

Dr Linda B. Baughn, Medical Geneticist, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

Dr Manoj Kumar, Stem Cell Laboratory Manager, Buhoot Equine Research Center, Dubai, UAE

Dr Mohammed Uddin, Assistant Professor, Human Genetics, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE

Nizar  Drou, Core Bioinformatics lead Developer, CGSB NYU, Abu Dhabi, UAE

Dr Pascal Joset, Professor, Institute of Medical Genetics, University of Zurich, Zurich, Switzerland

Dr Rabeah Abbas Al-Temaimi, Head of Human Genetic Unit, Department of Pathology Faculty of Medicine, Kuwait University, Kuwait

Dr Simon Patton, Director, European Molecular Genetics Quality Network (EMQN)c/o Manchester Centre for Genomic Medicine, Manchester, UK

 

 

Supported by: